867 related articles for article (PubMed ID: 26445202)
1. Implantable defibrillators versus medical therapy for cardiac channelopathies.
McNamara DA; Goldberger JJ; Berendsen MA; Huffman MD
Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD011168. PubMed ID: 26445202
[TBL] [Abstract][Full Text] [Related]
2. Implantable cardiac defibrillators for people with non-ischaemic cardiomyopathy.
El Moheb M; Nicolas J; Khamis AM; Iskandarani G; Akl EA; Refaat M
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012738. PubMed ID: 30537022
[TBL] [Abstract][Full Text] [Related]
3. Amiodarone versus other pharmacological interventions for prevention of sudden cardiac death.
Claro JC; Candia R; Rada G; Baraona F; Larrondo F; Letelier LM
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD008093. PubMed ID: 26646017
[TBL] [Abstract][Full Text] [Related]
4. Exercise-based cardiac rehabilitation for adult patients with an implantable cardioverter defibrillator.
Nielsen KM; Zwisler AD; Taylor RS; Svendsen JH; Lindschou J; Anderson L; Jakobsen JC; Berg SK
Cochrane Database Syst Rev; 2019 Feb; 2(2):CD011828. PubMed ID: 30746679
[TBL] [Abstract][Full Text] [Related]
5. Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2005; 5(14):1-74. PubMed ID: 23074465
[TBL] [Abstract][Full Text] [Related]
6. Perioperative beta-blockers for preventing surgery-related mortality and morbidity.
Blessberger H; Kammler J; Domanovits H; Schlager O; Wildner B; Azar D; Schillinger M; Wiesbauer F; Steinwender C
Cochrane Database Syst Rev; 2014 Sep; (9):CD004476. PubMed ID: 25233038
[TBL] [Abstract][Full Text] [Related]
7. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
[TBL] [Abstract][Full Text] [Related]
8. Systematic Review for the 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
Kusumoto FM; Bailey KR; Chaouki AS; Deshmukh AJ; Gautam S; Kim RJ; Kramer DB; Lambrakos LK; Nasser NH; Sorajja D
J Am Coll Cardiol; 2018 Oct; 72(14):1653-1676. PubMed ID: 29097297
[TBL] [Abstract][Full Text] [Related]
9. Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials.
Ezekowitz JA; Armstrong PW; McAlister FA
Ann Intern Med; 2003 Mar; 138(6):445-52. PubMed ID: 12639076
[TBL] [Abstract][Full Text] [Related]
10. Beta-blockers for preventing aortic dissection in Marfan syndrome.
Koo HK; Lawrence KA; Musini VM
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011103. PubMed ID: 29110304
[TBL] [Abstract][Full Text] [Related]
11. Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm.
Shantsila E; Lip GY
Cochrane Database Syst Rev; 2016 Sep; 9(9):CD003333. PubMed ID: 27629776
[TBL] [Abstract][Full Text] [Related]
12. Current Indications for Implantable Cardioverter Defibrillators in Non-Ischemic Cardiomyopathies and Channelopathies.
González-Torrecilla E; Arenal A; Atienza F; Datino T; Bravo L; Ruiz P; Ávila P; Fernández-Avilés F
Rev Recent Clin Trials; 2015; 10(2):111-27. PubMed ID: 25845953
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in patients with stroke or transient ischaemic attack.
Liu J; Wang LN
Cochrane Database Syst Rev; 2015 Oct; (10):CD010693. PubMed ID: 26511368
[TBL] [Abstract][Full Text] [Related]
14. A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.
Buxton M; Caine N; Chase D; Connelly D; Grace A; Jackson C; Parkes J; Sharples L
Health Technol Assess; 2006 Aug; 10(27):iii-iv, ix-xi, 1-164. PubMed ID: 16904046
[TBL] [Abstract][Full Text] [Related]
15. Complete versus culprit-only revascularisation in ST elevation myocardial infarction with multi-vessel disease.
Bravo CA; Hirji SA; Bhatt DL; Kataria R; Faxon DP; Ohman EM; Anderson KL; Sidi AI; Sketch MH; Zarich SW; Osho AA; Gluud C; Kelbæk H; Engstrøm T; Høfsten DE; Brennan JM
Cochrane Database Syst Rev; 2017 May; 5(5):CD011986. PubMed ID: 28470696
[TBL] [Abstract][Full Text] [Related]
16. Efficiencies and Complications of Dual Chamber versus Single Chamber Implantable Cardioverter Defibrillators in Secondary Sudden Cardiac Death Prevention: A Meta-analysis.
Hu ZY; Zhang J; Xu ZT; Gao XF; Zhang H; Pan C; Chen SL
Heart Lung Circ; 2016 Feb; 25(2):148-54. PubMed ID: 26338316
[TBL] [Abstract][Full Text] [Related]
17. Implantable cardioverter defibrillator therapy in young patients with cardiomyopathies and channelopathies: a single Italian centre experience.
Migliore F; Silvano M; Zorzi A; Bertaglia E; Siciliano M; Leoni L; De Franceschi P; Iliceto S; Corrado D
J Cardiovasc Med (Hagerstown); 2016 Jul; 17(7):485-93. PubMed ID: 27136702
[TBL] [Abstract][Full Text] [Related]
18. Implantable loop recorder versus conventional diagnostic workup for unexplained recurrent syncope.
Solbiati M; Costantino G; Casazza G; Dipaola F; Galli A; Furlan R; Montano N; Sheldon R
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD011637. PubMed ID: 27092427
[TBL] [Abstract][Full Text] [Related]
19. Medical therapy versus implantable cardioverter -defibrillator in preventing sudden cardiac death in patients with left ventricular systolic dysfunction and heart failure: a meta-analysis of > 35,000 patients.
Peck KY; Lim YZ; Hopper I; Krum H
Int J Cardiol; 2014 May; 173(2):197-203. PubMed ID: 24636548
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
